CDC Clinical Practice Guideline for Prescribing Opioids for Pain - Laser Therapy Now Recommended

"This guideline provides recommendations for clinicians providing pain care, including those prescribing opioids, for outpatients aged ≥18 years. It updates the CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016 (MMWR Recomm Rep 2016;65[No. RR-1]:1–49) and includes recommendations for managing acute (duration of <1 month), subacute (duration of 1–3 months), and chronic (duration of >3 months) pain."

"This clinical practice guideline is intended to improve communication between clinicians and patients about the benefits and risks of pain treatments, including opioid therapy; improve the effectiveness and safety of pain treatment; mitigate pain; improve function and quality of life for patients with pain; and reduce risks associated with opioid pain therapy, including opioid use disorder, overdose, and death."

"Clinicians should recommend appropriate noninvasive nonpharmacologic approaches to help manage chronic pain ... such as low-level laser therapy..."

READ THE FULL GUIDELINES HERE

Class 4 Laser Therapy: From Maligned Modality to Clinically Recommended Treatment

Class 4 therapy lasers were first FDA cleared in December 2003, and since then treatments have improved the quality of life for tens of thousands of human and animal patients. Those who criticize, defame, discredit, disgrace, impugn or in any way speak negatively about class 4 laser therapy need to stop it.